about
Lack of Cyp1b1 promotes the proliferative and migratory phenotype of perivascular supporting cellsGene set enrichment analysis provides insight into novel signalling pathways in breast cancer stem cells.MEOX2 regulates nuclear factor-kappaB activity in vascular endothelial cells through interactions with p65 and IkappaBbetaCollagen density regulates xenobiotic and hypoxic response of mammary epithelial cellsHigh microvessel density determines a poor outcome in patients with diffuse large B-cell lymphoma treated with rituximab plus chemotherapy.Topical antimicrobial photodynamic therapy improves angiogenesis in wounds of diabetic mice.Heme oxygenase-2 deletion causes endothelial cell activation marked by oxidative stress, inflammation, and angiogenesisROCK-isoform-specific polarization of macrophages associated with age-related macular degeneration.Microalgal carotenoids: beneficial effects and potential in human health.Nuclear factor-kappa-B signaling in lung development and disease: one pathway, numerous functions.Effects of NF-κB and hypoxia on the biological behavior of Y79 retinoblastoma cells.Inflammatory cytokines regulate endothelial cell survival and tissue repair functions via NF-κB signalingGensenoside Rg3 inhibits hypoxia-induced VEGF expression in human cancer cells.Obesity and Cancer Metabolism: A Perspective on Interacting Tumor-Intrinsic and Extrinsic FactorsAntiplatelet drug ticagrelor delays gastric ulcer healing in rats.Overcoming cancer therapy resistance by targeting inhibitors of apoptosis proteins and nuclear factor-kappa B.Computational simulations to predict creatine kinase-associated factors: protein-protein interaction studies of brain and muscle types of creatine kinases.Selective IKK2 inhibitor IMD0354 disrupts NF-κB signaling to suppress corneal inflammation and angiogenesis.Vialinin A, an Edible Mushroom-Derived p-Terphenyl Antioxidant, Prevents VEGF-Induced Neovascularization In Vitro and In Vivo.β₂-Glycoprotein I inhibits endothelial cell migration through the nuclear factor κB signalling pathway and endothelial nitric oxide synthase activation.
P2860
Q28585382-E03E18C3-98E6-468A-ADB7-702A40D830F4Q33620027-A479C364-A9F7-46B1-817F-A14580EC5700Q34062683-3F34BA23-0F21-4FEC-9F69-1C85E4FAA3F4Q35071054-47A1608B-E2AB-4BAF-9E2C-916498CD9E42Q35082512-8F97E9E4-8054-4616-9656-7D17B9FB21F5Q35687515-24D33276-D398-4E6C-B3E6-5882AA22C112Q37444467-28D93292-B374-4264-809A-02E9BAEC6AE4Q37570020-DFCC9B3E-54F1-442A-9E06-B834DA04B2C7Q38183609-CE25ED50-80F5-43D8-B597-12D02159014FQ38196790-BA2094C4-9D70-4C8E-8525-D8DB965F29DAQ38875102-7923E2A7-85FA-4740-8D96-5234BCA7DA94Q39181574-14A467E7-B199-4EF7-9FEA-A1F7BFBE6449Q39609595-9CE64D9E-D942-4F0C-B7F1-9B8286C6393BQ41673272-457AEBD6-50F9-4790-831A-99F7084C0579Q42376424-534DA4CF-D7E3-4ED8-975F-898C1C859051Q42632400-7C9ED8AC-5DC2-4D67-8540-41D6E6ECB096Q42855133-CD7FA544-51A0-4164-99F3-0A83DAB5FD71Q48248176-878965D9-2832-460E-8B6F-FCB3E8D2EF05Q52655088-B0FCE294-7EB1-48F7-A457-BD2491C8B54BQ54104640-6BD3B1B2-39AE-47F5-B271-F789768C9F07
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 19 February 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
NF-kappa B: a new player in angiostatic therapy
@en
NF-kappa B: a new player in angiostatic therapy.
@nl
type
label
NF-kappa B: a new player in angiostatic therapy
@en
NF-kappa B: a new player in angiostatic therapy.
@nl
prefLabel
NF-kappa B: a new player in angiostatic therapy
@en
NF-kappa B: a new player in angiostatic therapy.
@nl
P2860
P921
P1433
P1476
NF-kappa B: a new player in angiostatic therapy
@en
P2093
Arjan W Griffioen
Sebastien P Tabruyn
P2860
P2888
P304
P356
10.1007/S10456-008-9094-4
P577
2008-02-19T00:00:00Z